Mesenchymal Stem Cell-Derived Extracellular Vesicles for Regenerative Applications and Radiotherapy

Area of Science:

• Regenerative Medicine
• Biotechnology
• Tissue Engineering

Background:

• Tissue damage from disease, surgery, chemotherapy, and radiotherapy necessitates effective repair strategies.
• Current treatments for tissue repair are often costly, slow, and associated with complications like inflammation and cell damage.
• Mesenchymal stem cells (MSCs) exhibit tissue repair capabilities, but their therapeutic use can lead to immunological rejection.

Purpose of the Study:

• To review the research progress of MSC-derived EVs in promoting tissue repair.
• To highlight the potential of EVs as an alternative to MSC therapy for various tissue injuries.
• To explore the application of MSC-derived EVs in treating radiotherapy-induced tissue damage.

Main Methods:

• Review of existing scientific literature on MSC-derived EVs and their role in tissue repair.
• Analysis of studies investigating the mechanisms of EV-mediated tissue regeneration, anti-inflammation, and immune modulation.
• Compilation of evidence for EV efficacy across diverse tissue types, including heart, lung, liver, and central nervous system.

Main Results:

• MSC-derived EVs mimic the regenerative functions of MSCs.
• EVs demonstrate significant anti-inflammatory and pro-proliferative effects.
• Studies show efficacy of EVs in repairing damage across multiple organs and in radiation-induced injury models.

Conclusions:

• MSC-derived EVs offer a promising cell-free therapeutic approach for tissue repair.
• EVs present a viable alternative to MSC transplantation, avoiding immunological complications.
• This review provides insights into novel regenerative strategies for radiotherapy and other tissue damage applications.